Literature DB >> 3050001

Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease.

G A Weinberg1, D M Granoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3050001     DOI： 10.1016/s0022-3476(88)80369-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  19 in total

Review 1.  Effectiveness of Haemophilus influenzae type b vaccines.

Authors:  D M Stieb; H H Frayha; A D Oxman; H S Shannon; B G Hutchison; F S Crombie
Journal:  CMAJ       Date:  1990-04-01       Impact factor: 8.262

2.  Structural and antigenic conservation of the P2 porin protein among strains of Haemophilus influenzae type b.

Authors:  E J Hansen; S E Pelzel; K Orth; C R Moomaw; J D Radolf; C A Slaughter
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Immunizations in pediatrics: an update.

Authors:  E L Ford-Jones; R Gold
Journal:  Can Fam Physician       Date:  1990-09       Impact factor: 3.275

4.  Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. The Collaborative Vaccine Study Group.

Authors:  D M Granoff; P G Shackelford; S J Holmes; A H Lucas
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 5.  Content and dynamics of the human antibody variable region repertoire to the Haemophilus influenzae type b polysaccharide.

Authors:  D C Reason; A H Lucas
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Evaluation of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) in Canadian infants.

Authors:  D W Scheifele; G L Bjornson; W G Meekison; R Guasparini; L A Mitchell
Journal:  Can J Infect Dis       Date:  1994-03

7.  Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?

Authors:  D Scheifele; L Barreto; W Meekison; R Guasparini; B Friesen
Journal:  CMAJ       Date:  1993-10-15       Impact factor: 8.262

8.  A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.

Authors:  M A Liu; A Friedman; A I Oliff; J Tai; D Martinez; R R Deck; J T Shieh; T D Jenkins; J J Donnelly; L A Hawe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

9.  An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide.

Authors:  A H Lucas; R J Langley; D M Granoff; M H Nahm; M Y Kitamura; M G Scott
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

10.  Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants.

Authors:  Sarah W Satola; Patricia L Schirmer; Monica M Farley
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.